Market Overview

Benzinga's Top #PreMarket Losers

Related TRGT
Targacept Announces Negative Top-Line Results from Exploratory Study of TC-6499 in Diabetic Gastroparesis
Stocks Hitting 52-Week Lows
Related RMTI
8 Oppenheimer Analysts Choose Their Favorite Healthcare Stocks
Rockwell Medical Q4 Losses Wider Than Expected

Targacept (NASDAQ: TRGT) shares fell 31.93% to $4.05 in the pre-market trading after the company announced negative top-line results from Phase 2b clinical trial of TC-5619 in Schizophrenia.

Rockwell Medical (NASDAQ: RMTI) dipped 12.03% to $11.85. Brean Capital initiated coverage on the stock with a Sell rating.

Expedia (NASDAQ: EXPE) dipped 7.47% to $60.96 in the pre-market session. Expedia's trailing-twelve-month profit margin is 3.15%.

Fiserv (NASDAQ: FISV) shares dropped 3.21% to $54.87 in pre-market trading. Fiserv's PEG ratio is 2.67.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (EXPE + FISV)

Around the Web, We're Loving...

Get Benzinga's Newsletters